Search for: "Novartis Ag"
Results 241 - 260
of 440
Sort by Relevance
|
Sort by Date
8 Jan 2012, 8:24 pm
Certain bottles of Excedrin, NoDoz, Bufferin, and Gas-X are being recalled.BusinessWeek noted: Novartis AG said it’s voluntarily recalling some over-the-counter products in the U.S., including its Excedrin headache pills and NoDoz medication, because they may contain broken or stray tablets from other products.ANDNovartis said it was recalling all lots of bottles containing Excedrin and NoDoz with expiration dates of Dec. 20, 2014, or earlier as well as Bufferin and Gas-X… [read post]
13 Dec 2011, 6:06 am
http://www.businessweek.com/news/2011-12-13/novartis-confirms-patient-died-after-starting-gilenya-drug.html [read post]
1 Dec 2011, 6:31 am
In this case, Defendants were Merck & Co and Novartis AG. [read post]
17 Oct 2011, 11:24 am
Novartis AG [2011] EWHC 2403 (Pat). [read post]
17 Oct 2011, 4:53 am
Court of Appeal (Civil Division) Daventry District Council v Daventry & District Housing Ltd [2011] EWCA Civ 1153 (13 October 2011) High Court (Queen’s Bench Division) Woodland v The Swimming Teachers’ Association & Ors [2011] EWHC 2631 (QB) (17 October 2011) High Court (Commercial Court) All Leisure Holidays Ltd v Europaische Reiseversicherung AG & Ors [2011] EWHC 2629 (Comm) (17 October 2011) High Court (Patents Court) Generics (UK) Ltd (t/a Mylan) v… [read post]
12 Oct 2011, 3:46 am
No (FDA Law Blog) US: Patent battle over modified meganucleases heats up: Cellectis v Precision Biosciences (Holman’s Biotech IP Blog) (Patent Docs) US: Landmark NORD report on orphan drugs authored by HP&M Director shows FDA flexibility in approval (FDA Law Blog) Products Embeda (Morphine sulfate, Naltrexone hydrochloride) – US: Pfizer, Alpharma, King Pharma. file patent infringement suit against Watson following Para IV certification (Patent Docs) Exelon (Rivastigmine)… [read post]
10 Oct 2011, 12:31 am
"We can now confirm that the deadline to submit comments on Case C- 442/11 Novartis AG v Actavis UK Limited is 14 October 2011" writes the UK Intellectual Property Office, which adds "If you would like to comment on this case please e-mail policy@ipo.gsi.gov.uk before 14 October 2011". [read post]
3 Oct 2011, 5:20 am
In addition, Mr Alexander talked the packed auditorium through some interesting procedural decisions, such as Virgin Atlantic v Delta Air on summary judgment, Cephalon v Orchid on interim injunctions or MedImmune v Novartis on expert evidence. [read post]
28 Sep 2011, 1:56 am
The AG’s opinion in Georgetown and Medeva (The SPC blog) Hungary: Repeatedly filed request for preliminary injunction – micronized active ingredient (EPLAW) Indonesia pharma patents and generic manufacture (IP Komodo) South Africa: Traditional Knowledge Bill debate – your views needed (Afro-IP) (Afro-IP) (Afro-IP) UK: Second round consultation on Patent Box proposal (including SPCs) ends (The SPC Blog) US: CAFC: Patent exhaustion does not apply to genetically engineered… [read post]
21 Sep 2011, 2:36 am
Novartis AG v Actavis UK Limited (The SPC blog) (The SPC blog) Europe: Note on recent ECJ Memantine and Galantamine rulings (The SPC blog) US: Federal Circuit denies petition for rehearing in AMP v. [read post]
15 Sep 2011, 12:38 pm
Watson Pharmaceuticals and the Sandoz unit of Novartis AG are the latest companies to settle with the federal and several state governments as a result of ongoing litigation brought by Ven-A-Care of the Florida Keys alleging that several manufacturers overcharged Medicaid for prescription drugs by inflating their Average Wholesale Prices. [read post]
13 Sep 2011, 4:26 pm
Switzerland, home to companies including drugmaker Novartis AG (NOVN) and food company Nestle SA (NESN), was credited for its innovation and technological skills. [read post]
7 Sep 2011, 3:53 am
The Wall Street Journal reports that the Food and Drug Administration has updated a warning regarding kidney failure and use of Novartis’ Reclast (zoledronic acid). [read post]
1 Sep 2011, 1:12 pm
Osteoporosis is simply part of the natural aging process. [read post]
30 Aug 2011, 5:18 am
Teva, the world's largest generic drug company, won a court battle in SDNY in its role as a proprietary drug company making Copaxone, against Novartis AG's Sandoz unit, Momenta Pharmaceuticals Inc., Mylan Inc., and Natco Pharma Ltd. [read post]
27 Aug 2011, 7:55 pm
AG v. [read post]
16 Aug 2011, 11:35 pm
General Medicines Patent Pool faces licensing issues (Spicy IP) Australia: Pharmaceuticals – copyright in PIs and indirect patent infringement: Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 3) (Mallesons) China: One out of three seeds in China infringes patents (IP Dragon) EU: More comments to the AG opinion in Medeva (The SPC Blog) EU: Patent term extensions – uncertainty and disharmony: an overview (The SPC Blog) India: NGO alleges ‘bio-piracy’ by… [read post]
14 Aug 2011, 9:11 am
A recent editorial in the Annals of Occupational Hygiene is a poignant reminder of how oversold peer review is in the context of expert witness judicial gatekeeping. [read post]
27 Jul 2011, 1:01 am
General Decision for WIPO GA 49: Matters concerning the IGC on IP and genetic resources, traditional knowledge and folklore (KEI) (IP Watch) (IP Watch) Corporate self-interest and strategic choices: Gilead licenses to Medicines Patent Pool (IP Watch) (KEI) Global biotechnology IP evaluation by Scientific American (BIOtechNOW) The Bucknell book – ‘Pharmaceutical, Biotechnology and Chemical Inventions: World Protection and Exploitation’ (The SPC Blog) Dr Reddy’s finds… [read post]
5 Jul 2011, 1:44 pm
The patents were owned jointly by MedImmune and MRC, who alleged that they had been infringed by Novartis’ sales of ranibizumab, a pharmaceutical product sold under the trade mark Lucentis and is approved for the treatment of an eye condition known as wet age-related macular degeneration. [read post]
